Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Complimentary download
Cellectis Plant Sciences and Two Blades Foundation announce the execution of a cross-license agreement on TAL Effector Nuclease technologies
Recommend Report
Need some help to find your information ?
E-mail:
econtact@cnchemicals.com
Tel: +86-20-37616606
Search Report
Agriculture
Biotechnology
Chemicals
Economics and investment and financial
Energy and utilities
Food and Feed
Food and Feed (Ingredients)
Minerals/resources/mining
Pharmaceuticals and healthcare
Printing & packaging
More Reports >>
Recommend Newsletter
Related market data
Related product
Related research
Cellectis Plant Sciences and Two Blades Foundation announce the execution of a cross-license agreement on TAL Effector Nuclease technologies
Keyword:
Publish time:
18
th
December, 2014
Source:
New Brighton, Minnesota and Evanston, Illinois, USA
Information collection and data processing: CCM For more information, please
contact us
Cellectis Plant Sciences and Two Blades Foundation announce the execution of a cross-license agreement on TAL Effector Nuclease technologiesCellectis Plant Sciences and Two Blades Foundation announce the execution of a cross-license agreement on TAL Effector Nuclease
technologies
" title="Share this link on Facebook">New Brighton, Minnesota and Evanston, Illinois, USADecember 18, 2014Cellectis plant sciences, a Minnesota-based company focusing on developing healthier
food
products, and the Two Blades Foundation (2Blades) today announced the execution of a non-exclusive cross-license agreement relating to TAL nuclease technologies.Pursuant to the agreement, 2Blades receives a license to TALEN™ technology for not-for-profit uses, including use in 2Blades’ humanitarian efforts to support subsistence farming, and for certain commercial applications related to the disease resistance programs of 2Blades. In addition, pursuant to the agreement, Cellectis plant sciences receives a license under 2Blades’ TAL Code technology related to nucleases for commercial uses in certain specified crop plants. Cellectis plant sciences has an option to expand its license to additional
crops
. Financial terms of the agreement were not disclosed.“2Blades is pleased to enter into a cross-licensing agreement with Cellectis plant sciences,” said Diana Horvath, 2Blades’ President. “It streamlines the use of this powerful gene-editing technology in agriculture, fitting well with 2Blades’ interest in seeing broad use of the technology for a wide range of commercial and subsistence applications that we believe will benefit farmers and consumers.”“We are delighted to collaborate with the Two Blades Foundation to support its humanitarian effort to reduce the impact of plant diseases in developing countries,” commented Luc Mathis, Chief Executive Officer of Cellectis plant sciences. “The agreement also provides a unique foundation for the commercial development of healthier food products with the objective to expedite their availability to consumers.”The TAL Code technology and TALEN™ technology are useful tools that target genes at precise sites and enable specific regulation of gene expression. The technology is based on novel DNA-binding proteins that can be designed to cleave at any selected region in any gene.The TAL Code technology is covered bypatents and patent applications based on the international application WO2010/079430,which names as inventors Ulla Bonas, Jens Boch, Thomas Lahaye, and Sebastian Schornack of Martin-Luther University in Halle, Germany. The Two Blades Foundation holds exclusive, worldwide rights for commercial uses of the technology in plants and has undertaken a broad licensing program involving this technology.The TALEN™ technology is covered by patents and patent applications based on the international application WO2011/072246,which names as inventors Dan Voytas, Adam Bogdanove, Feng Zhang, Michelle Christian, Tomas Cermak, Clarice Lauer Schmidt, Erin Doyle and Li Wang of Iowa State University and the University of Minnesota, USA. Cellectis holds an exclusive, worldwide license from the University of Minnesota under this technology in all fields of use.About 2BladesThe Two Blades Foundation is a 501(c)3 not-for-profit corporation dedicated to developing durable disease resistance in agricultural crops. The Foundation establishes and runs programs to support and implement solutions to significant unsolved crop disease problems, both in the developing world and in major agricultural markets. 2Blades oversees a number of development programs in collaboration with leading academic institutions around the world, as well as a significant portfolio of technologies, which it brings into practical use through partnering and licensing.About Cellectis plant sciencesFounded in 2010, Cellectis plant sciences is based in New Brighton, Minnesota (United States). The company has developed a platform to improve the quality of crops for the food and agriculture industries. Cellectis plant sciences is involved in a network of collaborations that include global companies (Bayer, Limagrain,
Monsanto
, SESVanderhave among others), as well as leading healthcare (Mitsubishi Tanabe Pharma) and food companies. Cellectis plant sciences is developing innovative products with prominent partners with the aim of making its products accessible to consumers.More news from:. Cellectis SA. Two Blades FoundationWebsite: http://www.cnchemicals.com/: December 18, 2014The news item on this page is copyright by the organization where it originatedFair use notice
Index Type:(required)
-- Please select --
Message:(required)
Name:(required)
Email:(required)
Tel:
Message:(required)
Name:(required)
Email:(required)
Tel: